Browse > Article
http://dx.doi.org/10.14476/jomp.2014.39.1.29

Mucormycosis: A Case Report and Review of Literature  

Lee, Guem-Sug (Department of Dentistry, Chonnam National University Hwasun Hospital)
Lee, Kyung-Hwa (Department of Pathology, Chonnam National University Hwasun Hospital)
Kim, Byung-Gook (Department of Oral Medicine, School of Dentistry, Chonnam National University)
Im, Yeong-Gwan (Department of Oral Medicine, Chonnam National University Dental Hospital)
Publication Information
Journal of Oral Medicine and Pain / v.39, no.1, 2014 , pp. 29-33 More about this Journal
Abstract
Mucormycosis is a rare but fatal fungal infection with low survival rate in immune-compromised patients. It is caused by a fungus belonging to the Mucoraceae family of the Zygomycetes class. Mucormycosis is classified as rhino-orbital-cerebral, pulmonary, cutaneous, gastrointestinal, disseminated, and miscellaneous types according to its clinical manifestations. Early diagnosis and treatment along with correction of the underlying medical condition is important for favorable results. This case presentation describes mucormycosis involving the anterior maxillary region in a leukemic patient with prolonged neutropenia. The patient benefited from a timely biopsy and immediate treatment with amphotericin B, and was successfully managed with an interdisciplinary team approach consisting of dental and several medical specialists.
Keywords
Amphotericin B; Head; Leukemia; Mucormycosis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634-653.   DOI   ScienceOn
2 Tamgadge AP, Mengi R, Tamgadge S, Bhalerao SS. Chronic invasive aspergillosis of paranasal sinuses: a case report with review of literature. J Oral Maxillofac Pathol 2012;16:460-464.   DOI
3 Paltauf A. Mycosis mucorina: ein beitrag zur kenntniss der menschlichen fadenpilzerkrankungen. Virchows Arch Path Anat 1885;102:543-564.   DOI
4 Gregory JE, Golden A, Haymaker W. Mucormycosis of the central nervous system: a report of three cases. Bull Johns Hopkins Hosp 1943;73:405-419.
5 Adams JG. Emergency medicine: clinical essentials. 2nd ed. Philadelphia: Saunders; 2012. pp. 1483-1490.
6 Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.   DOI   ScienceOn
7 Severo CB, Guazzelli LS, Severo LC. Chapter 7: zygomycosis. J Bras Pneumol 2010;36:134-141.   DOI
8 Garg R, Gupta VV, Ashok L. Rhinomaxillary mucormycosis: a palatal ulcer. Contemp Clin Dent 2011;2:119-123.   DOI
9 Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635-648.
10 Gonzalez Ballester D, Gonzalez-Garcia R, Moreno Garcia C, Ruiz-Laza L, Monje Gil F. Mucormycosis of the head and neck: report of five cases with different presentations. J Craniomaxillofac Surg 2012;40:584-591.   DOI
11 Singh V, Sharma B, Sen R, Agrawal S, Bhagol A, Bali R. Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host. J Oral Maxillofac Surg 2012;70:1369-1375.   DOI
12 Waness A, Dawsari GA, Al Jahdali H. The rise of an opportunistic infection called "Invasive Zygomycosis". J Glob Infect Dis 2009;1:131-138.   DOI
13 Shoham S, Marr KA. Invasive fungal infections in solid organ transplant recipients. Future Microbiol 2012;7:639-655.   DOI
14 Tragiannidis A, Roilides E, Walsh TJ, Groll AH. Invasive aspergillosis in children with acquired immunodeficiencies. Clin Infect Dis 2012;54:258-267.   DOI
15 Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006;91:1068-1075.
16 Viterbo S, Fasolis M, Garzino-Demo P, et al. Management and outcomes of three cases of rhinocerebral mucormycosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:e69-e74.   DOI
17 Jung SH, Kim SW, Park CS, et al. Rhinocerebral mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx 2009;36:274-279.   DOI
18 Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. 7th ed. Philadelphia: Saunders; 2012. pp. 631-642.
19 Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009;48:1743-1751.   DOI   ScienceOn
20 Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis 2011;11:301-311.   DOI
21 Laza-Stanca V, Reid L, Watson JD, Williamson EC. Successful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patient. J Plast Reconstr Aesthet Surg 2012;65:1259-1261.   DOI
22 Leitner C, Hoffmann J, Zerfowski M, Reinert S. Mucormycosis: necrotizing soft tissue lesion of the face. J Oral Maxillofac Surg 2003;61:1354-1358.   DOI
23 Rammaert B, Lanternier F, Poiree S, Kania R, Lortholary O. Diabetes and mucormycosis: a complex interplay. Diabetes Metab 2012;38:193-204.   DOI   ScienceOn
24 Pfalle MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006;43:S3-S14.   DOI   ScienceOn
25 Wu VC, Wang R, Lai TS, Wu KD. Deferoxamine-related fatal nasal-orbital-cerebral mucormycosis. Kidney Int 2006;70:1888.   DOI
26 Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood 2011;118:1216-1224.   DOI
27 Lee HJ, Kwon JC, Kim SH, et al. Posaconazole treatment in Korea: single-center experience over 5 years. Yonsei Med J 2013;54:1234-1240.   DOI
28 Cohnheim J. Zwei falle von mykosis der lungen. Virchows Arch Path Anat 1865;33:157.   DOI
29 Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. J Neurol Sci 1996;143:19-30.   DOI